Navigation Links
Patient Temperature Management Systems Enjoying Wider Usage
Date:11/19/2008

LONDON, Nov. 19 /PRNewswire/ -- With issues around patient comfort gaining momentum, hospitals and healthcare decision makers are recognising the need to consider patients' relief and welfare. This is leading to a growing demand for patient temperature management systems, which are being used for a greater number of patients and not just the aged and weak.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), European Patient Temperature Management Systems, finds that the market earned revenues of $366.0 million in 2007 and estimates this to reach $999.0 million in 2014.

"Heightened awareness about the numerous benefits of patient temperature management systems in surgical settings is aiding their increased uptake," notes Frost & Sullivan Industry Analyst Radha Sawhny. "The increasing proof of the long-term health benefits and reduced risks of contracting disease and infection in an operating environment they offer are the strong reasons for the demand."

Some patient temperature management systems are more established, their merits better known and, hence, their adoption rates higher than others. However, one of the biggest challenges in the European patient temperature management systems market relates to the lack of information about the varied merits of the systems on offer.

The market has two categories of products. The first are those aimed at therapeutic hypothermia and the reduction of fever with the use of surface and invasive warming and cooling devices. The second category includes those that maintain normothermia (normal body temperature) in patients exposed to the surgical environment and due for a surgical procedure. These therapies include convective warming and blood and fluid warming systems.

"The challenge lies in promoting the uptake of both product types," remarks Sawhny. "While the merits of induced hypothermia are well understood in some clinical situations, convincing the medical community that normothermia management in all surgical patients is beneficial continues to face stiff resistance. Cost-conscious countries in Europe are particularly hesitant to adopt these devices on a larger scale, as market awareness is relatively low."

Even though hospital staff and healthcare workers are realising the significance of implementing these therapies, the reluctance to use them widely due to the cost is impeding market expansion. Therefore, hospital administrators (who are severely constrained by tight budgetary controls) need to be convinced of the long-term cost benefits of applying these therapies in terms of their reducing patient recovery times and duration of hospital stay.

"Manufacturers of different temperature management systems need to develop focused information dissemination strategies aimed at highlighting the specific merits of these therapies," opines Sawhny. "Creating a presence in both types of therapies as well as investing in product development with an emphasis on less bulky, less noisy and easy-to-use products within the operating room environment will be crucial to advance market prospects."

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the European patient temperature management systems market, then send an e-mail to Patrick Cairns, Corporate Communications, at pcairns_pr@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

European Patient Temperature Management Systems Market is part of the Medical Devices Growth Partnership Services programme, which also includes research in the following markets: cardiovascular, wound care, surgical, orthopaedic and others. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.frost.com.

               European Patient Temperature Management Systems
                                     M286

     Contact:
     Patrick Cairns
     Corporate Communications
     P: +27 18 468 2315
     E: patrick.cairns@frost.com

    http://www.frost.com

'/>"/>
SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cancer survival rates impact type of Web communities used by patients
2. Indigo Ointment Benefits Psoriasis Patients
3. A postcode lottery still exists for cancer patients with exceptional circumstances
4. U of U researchers to use patients own stem cells to treat heart failure
5. Predicting the future for patients with severe traumatic brain injury
6. CAPHOSOL results in minimal oral mucositis and pain in head/neck cancer patients
7. Canadian cold/flu breakthrough remedy undergoes NCI-sponsored trial in leukemia patients
8. Intervention program boosts survival in breast cancer patients
9. Lung Cancer Genetics Different in Black Patients: Study
10. High Blood-Pressure Patients Can See Improvement Through Guided Breathing
11. Lung Cancer Patients Get Blamed for Their Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... 2017 , ... Studies show evidence that carotenoids and antioxidants derived either from ... these patients. , But how often do ophthalmologists and optometrists in Sweden recommend the ... of or with early symptoms of AMD? A study published recently in ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will ... 20. , The two-day conference is focused on advancing scientific knowledge about the ... lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance ... With the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more ... 2012, the Biggert-Waters Act was enacted to reflect the actual risk in flood ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... planning services to communities in the greater Chicago metropolitan area, is embarking on ... to underprivileged youth in Chicago. , Founded in 1897, Hephzibah Children’s Association is ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: